Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Non-Current Debt (2019)

Historic Non-Current Debt for Avidity Biosciences (RNA) over the last 1 years, with Q4 2019 value amounting to $1.8 million.

  • Avidity Biosciences' Non-Current Debt changed N/A to $1.8 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $1.8 million for FY2019, which is N/A changed from last year.
  • Per Avidity Biosciences' latest filing, its Non-Current Debt stood at $1.8 million for Q4 2019.
  • Avidity Biosciences' 5-year Non-Current Debt high stood at $1.8 million for Q4 2019, and its period low was $1.8 million during Q4 2019.